Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17229796rdf:typepubmed:Citationlld:pubmed
pubmed-article:17229796lifeskim:mentionsumls-concept:C0010346lld:lifeskim
pubmed-article:17229796lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:17229796lifeskim:mentionsumls-concept:C0021079lld:lifeskim
pubmed-article:17229796lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:17229796lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:17229796lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:17229796lifeskim:mentionsumls-concept:C1280519lld:lifeskim
pubmed-article:17229796pubmed:issue9lld:pubmed
pubmed-article:17229796pubmed:dateCreated2007-8-16lld:pubmed
pubmed-article:17229796pubmed:abstractTextEpisodic infliximab (IFX) treatment is associated with the formation of antibodies to IFX (ATIs) in the majority of patients, which can lead to infusion reactions and a shorter duration of response. Concomitant use of immunosuppressives (IS) reduces the risk of ATI formation.lld:pubmed
pubmed-article:17229796pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:languageenglld:pubmed
pubmed-article:17229796pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17229796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17229796pubmed:statusMEDLINElld:pubmed
pubmed-article:17229796pubmed:monthSeplld:pubmed
pubmed-article:17229796pubmed:issn0017-5749lld:pubmed
pubmed-article:17229796pubmed:authorpubmed-author:RutgeertsPaul...lld:pubmed
pubmed-article:17229796pubmed:authorpubmed-author:BaertFilipFlld:pubmed
pubmed-article:17229796pubmed:authorpubmed-author:D'HaensGeertGlld:pubmed
pubmed-article:17229796pubmed:authorpubmed-author:VermeireSever...lld:pubmed
pubmed-article:17229796pubmed:authorpubmed-author:NomanMajaMlld:pubmed
pubmed-article:17229796pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:17229796pubmed:issnTypePrintlld:pubmed
pubmed-article:17229796pubmed:volume56lld:pubmed
pubmed-article:17229796pubmed:ownerNLMlld:pubmed
pubmed-article:17229796pubmed:authorsCompleteYlld:pubmed
pubmed-article:17229796pubmed:pagination1226-31lld:pubmed
pubmed-article:17229796pubmed:dateRevised2010-9-2lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:meshHeadingpubmed-meshheading:17229796...lld:pubmed
pubmed-article:17229796pubmed:year2007lld:pubmed
pubmed-article:17229796pubmed:articleTitleEffectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.lld:pubmed
pubmed-article:17229796pubmed:affiliationDepartment of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.lld:pubmed
pubmed-article:17229796pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17229796pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17229796pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17229796lld:pubmed